333 Hospital physicians’ and older patients’ agreement with individualised STOPP/START recommendations small numbers with varying agreement e.g. inhaled bronchodilators (N=12; 33.3% agreement), analgesics (N=7; agreement 28.6%). The 10 most prevalent STOPP recommendations, comprising 87.3% (N=207) of all discussed STOPP recommendations and their subsequent agreement by both patient and attending physician after discussion with PT are listed in Figure 3. Some of these individual criteria contain STOPP recommendations for the same medication (or drug class) but were based on other reasons for inappropriateness. For example, implementing STOPP criteria D5 and K1 both result in discontinuation advice for benzodiazepines. Agreement with recommendations based on START criteria Of the 134 START criteria discussed with patients and their attending physicians by the PT, 60.7% were agreed upon. An overview of the 10 most prevalent START recommendations, comprising 89.6% (N=120) of all START recommendations discussed and subsequent agreement, is displayed in Figure 4. Figure 3. Top 10 STOPP recommendations and corresponding agreement by patient and attending physician after discussion with PT. STOPP A1: ‘No evidence-based clinical indication’ contains stop recommendations for multiple medications with ‘drugs for acid related disorders’ being themost prevalent (43.2%of STOPP A1). 4
RkJQdWJsaXNoZXIy MTk4NDMw